DLL4 Antibody (C-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS: 1
- PROTOCOLS
- BACKGROUND
Application ![]()
| WB, FC, IHC-P, E |
---|---|
Primary Accession | Q9NR61 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 74605 Da |
Antigen Region | 625-652 aa |
Gene ID | 54567 |
---|---|
Other Names | Delta-like protein 4, Drosophila Delta homolog 4, Delta4, DLL4 |
Target/Specificity | This DLL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 625-652 amino acids from the C-terminal region of human DLL4. |
Dilution | WB~~1:1000 IHC-P~~1:50~100 FC~~1:10~50 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | DLL4 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | DLL4 |
---|---|
Function | Involved in the Notch signaling pathway as Notch ligand (PubMed:11134954). Activates NOTCH1 and NOTCH4. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting (PubMed:20616313). Essential for retinal progenitor proliferation. Required for suppressing rod fates in late retinal progenitors as well as for proper generation of other retinal cell types (By similarity). During spinal cord neurogenesis, inhibits V2a interneuron fate (PubMed:17728344). |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Tissue Location | Expressed in vascular endothelium. |

Provided below are standard protocols that you may find useful for product applications.
Background
DLL4 is a homolog of the Drosophila delta gene. The delta gene family encodes Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain.
References
Emuss, V., et al. PLoS Pathog. 5 (10), E1000616 (2009)
Ferrari-Toninelli, G., et al. Dev Neurobiol 69(6):378-391(2009)
Indraccolo, S., et al. Cancer Res. 69(4):1314-1323(2009)
Segarra, M., et al. Blood 112(5):1904-1911(2008)

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.